# inCerebro Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/incerebro-co

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Website: www.incerebro.com
- Latest round: Seed (Oct 1, 2019)
- Investors on record: 2

## About

Based in Seoul, South Korea and founded in 2019, inCerebro Co., Ltd. is a research-oriented company for drug development. The company designs new drugs using molecular modeling and AI technology. In 2019, its research institute was established. The next year, 2020, a research collaboration for ICRB-001 with Eulji University and AI platform completion took place.

The company uses AI technology to develop anti-cancer medicines namely, ICRB-001, ICRB-002, ICRB-501, and ICRB-502.

## Funding rounds

- Seed, Oct 1, 2019 — Korea Tech Incubator for Startup, Korea University Holdings
- Seed, Jun 1, 2019 — Korea University Holdings

## Investors

- Korea University Holdings (https://capitalatlas.ai/funds/korea-university-holdings) — Seed
- Korea Tech Incubator for Startup — Seed